Prostatype Genomics AB (publ) at its annual general meeting held on June 2, 2022, Mattias Prage was elected as new member of the board.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0235 SEK | -47.19% | -52.53% | -75.26% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-75.26% | 2.21M | |
-21.01% | 8.05B | |
+68.16% | 4.32B | |
+6.69% | 2.74B | |
-2.98% | 2.6B | |
-50.95% | 1.97B | |
-18.54% | 1.68B | |
-21.29% | 1.45B | |
+16.69% | 1.2B | |
-44.86% | 1.12B |
- Stock Market
- Equities
- PROGEN Stock
- News Prostatype Genomics AB
- Prostatype Genomics AB Appoints Mattias Prage as Member of the Board